Loading...
Market
What will be Colossal Biosciences' valuation by end of 2025?
3
Resolution / Starting Odds
$15 billion • 25%
$20 billion • 25%
$25 billion • 25%
Other • 25%
Financial reports or official press releases from Colossal Biosciences
Story
Colossal Biosciences Raises $200M, Valued at $10.2B to Revive Woolly Mammoth, Dodo, and Tasmanian Tiger
Jan 15, 2025, 09:15 PM
Colossal Biosciences, a Dallas-based startup focused on de-extinction, has raised $200 million in a Series C funding round, bringing its valuation to $10.2 billion. The company, which aims to revive extinct species such as the woolly mammoth, dodo, and Tasmanian tiger, has now secured a total of $435 million in funding since its inception in 2021. The latest round was led by TWG Global, with Mark Walter and Thomas Tull at the helm. Colossal plans to use the new funds to expand its team, develop new technologies, and broaden its list of species targeted for de-extinction.
View original story
Similar markets
$5B to $10.2B • 25%
Above $15B • 25%
$10.2B to $15B • 25%
Below $5B • 25%
Yes • 50%
No • 50%
The Nature Conservancy • 25%
Conservation International • 25%
WWF • 25%
Other • 25%
More than 3 new species • 25%
1 new species • 25%
2 new species • 25%
3 new species • 25%
$6 billion • 25%
Over $8 billion • 25%
$8 billion • 25%
$7 billion • 25%
$3 billion to $5 billion • 25%
Less than $3 billion • 25%
$5 billion to $10 billion • 25%
Over $10 billion • 25%
$1 billion to $5 billion • 25%
$500 million to $1 billion • 25%
More than $5 billion • 25%
Less than $500 million • 25%
$7 billion to $9 billion • 25%
Above $9 billion • 25%
Below $5 billion • 25%
$5 billion to $7 billion • 25%
$4 billion • 25%
$2 billion • 25%
Over $4 billion • 25%
$3 billion • 25%
Below $350 billion • 25%
Above $450 billion • 25%
$400 billion to $450 billion • 25%
$350 billion to $400 billion • 25%